USFDA completes inspection of Lupin's Aurangabad facility

16 May 2019 Evaluate

The United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Aurangabad manufacturing facility. The inspection was carried out from May 6 to May 15, 2019.

The inspection at the Aurangabad facility closed with three observations. The company is confident of addressing them satisfactorily.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2181.45 -9.05 (-0.41%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×